Daoyuan Capital
Beijing, Beijingtaocapital.cn
Overview
Daoyuan Capital is a venture capital investment firm that is based in Beijing, China . The firm focuses on the medical and health industry covering all stages of enterprise growth such as start-up, growth, and maturity .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| KangaBio | Jun 2023 | Early Funding | Lead |
| Syrebo | Mar 2023 | Series A | Co-investor |
| 4B Technologies | Dec 2022 | Series B | Co-investor |
| 苏州易慕峰生物科技有限公司 | Jan 2022 | Series A | Co-investor |
| BriSTAR Immunotech | Oct 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
